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Abstract This paper provides recommendations on
experimental design for early-tier laboratory studies
used in risk assessments to evaluate potential adverse
impacts of arthropod-resistant genetically engineered
(GE) plants on non-target arthropods (NTAs). While
we rely heavily on the currently used proteins from
Bacillus thuringiensis (Bt) in this discussion, the
concepts apply to other arthropod-active proteins.
A risk may exist if the newly acquired trait of the GE
plant has adverse effects on NTAs when they are
exposed to the arthropod-active protein. Typically,
the risk assessment follows a tiered approach that
starts with laboratory studies under worst-case expo-
sure conditions; such studies have a high ability to
detect adverse effects on non-target species. Clear
guidance on how such data are produced in labora-
tory studies assists the product developers and risk
assessors. The studies should be reproducible and test
clearly defined risk hypotheses. These properties
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contribute to the robustness of, and confidence in,
environmental risk assessments for GE plants. Data
from NTA studies, collected during the analysis
phase of an environmental risk assessment, are
critical to the outcome of the assessment and
ultimately the decision taken by regulatory authori-
ties on the release of a GE plant. Confidence in the
results of early-tier laboratory studies is a precondi-
tion for the acceptance of data across regulatory
jurisdictions and should encourage agencies to share
useful information and thus avoid redundant testing.
Keywords Environmental risk assessment 
Non-target effects  Study design  Tiered risk
assessment  Transgenic crops
Introduction
Genetically engineered (GE) plants and food and feed
products derived from them are strictly regulated by
governments internationally. Through the implemen-
tation of regulatory systems, designated authorities
mandate a pre-market environmental risk assessment
and a food/feed safety assessment of GE events case-
by-case. These evaluations are a prerequisite to the
regulatory decision to approve or not approve GE
events for cultivation and for human food and/or
livestock feed consumption.
Environmental risk assessment of GE plants is
designed to answer very specific questions about the
potential risks of introducing such plants into the
environment, and includes three main phases: problem
formulation, analysis (data collection), and risk char-
acterization (USEPA 1998; Raybould 2006; Carstens
et al. 2010; Wolt et al. 2010). Identification of
protection goals (e.g., the protection of valued arthro-
pods) is a crucial early step in problem formulation.
Protection goals reflect the social, cultural, economic,
environmental, and related development objectives of
a country, and therefore are typically specific to each
regulatory system (Raybould and Quemada 2010).
However, among different regulatory authorities there
are some common areas of concern. One of these
concerns, and the subject of this paper, is potential
adverse impacts that a GE plant may have on non-
target arthropods (NTAs),1 and in particular adverse
effects that may arise through exposure to toxins
produced in arthropod-resistant GE crops. The mag-
nitude of risk to NTAs depends on the likelihood and
seriousness of harmful effects that may result from
cultivation of the crop. Generation of relevant effects
and exposure data for such toxins is fundamental for
any assessment of impacts on NTAs.
Testing of hypotheses about the likelihood of harmful
effects of cultivating the GE plant using data collected in
the analysis phase is crucial to the outcome of the risk
assessment and ultimately the decision taken by regu-
latory authorities on the release of a GE plant. Useful
data of sufficient quality may already exist in the
scientific literature or previously conducted studies, or
may be acquired from new studies carried out especially
for the risk assessment. WHO (2008) described four
qualitative criteria that indicate data quality in studies
used for chemical exposure assessment:
1. Appropriateness: The degree to which data are
relevant and applicable to a particular exposure
assessment.
2. Accuracy: The degree to which measured, cal-
culated, or modeled values correspond to the true
values of what they are intended to represent.
3. Integrity: The degree to which the data collected
and reported are what they purport to be.
4. Transparency: The clarity and completeness with
which all key data, methods, and processes, as well as
the underlying assumptions and limitations, are
documented and available.
A. M. Shelton
Cornell University/NYSAES, 630 W. North St., Geneva,
NY 14456, USA
A. Waggoner
Office of Pesticide Programs, Biopesticides and Pollution
Prevention Division, US Environmental Protection
Agency, 1200 Pennsylvania Avenue, NW, Washington,
DC 20460, USA
1 As current and near future commercial products target
arthropod pests, this paper focuses more narrowly on direct
effects on this group of animals as a sub-group of non-target
organisms (NTOs). A further restriction is that non-target
arthropods (NTAs) are generally considered beneficial as
opposed to non-target pests. The concepts discussed here will
apply to other non-target invertebrates, e.g., earthworms and
nematodes.
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The importance and applicability of these ‘‘hall-
marks of data quality’’ (WHO 2008) to the
environmental risk assessment of GE plants has
been recognized implicitly or explicitly by regula-
tory authorities who have attempted to define
mutually acceptable quality standards for chemical
exposure in regulatory submissions. These same
standards should also apply to GE plants. For
example, the Risk Analysis Framework published
by the Australian Office of the Gene Technology
Regulator (OGTR 2009) addresses the quality of
evidence (Table 1). The provision of such guidance
about data quality assists both the product developer
and strengthens the robustness of the risk
assessment.
This paper summarizes the outcomes of expert
panels convened by the West Palaearctic Regional
Section of the International Organisation for Biolog-
ical Control (IOBC/WPRS) in 2007 and the Interna-
tional Life Sciences Institute (ILSI) Research
Foundation in 2009, with additional contributions
from subject matter experts. It provides guidance and
recommendations on experimental design for early-
tier laboratory studies (termed Tier I and/or Tier II
studies depending on the jurisdiction) used to eval-
uate potential adverse effects of arthropod-resistant
GE plants on NTAs. The specific recommendations
provided herein may be viewed as the basic quality
standard for early-tier NTA studies used to support
regulatory submissions.
Assessment of GE plant effects on non-target
arthropods
Problem formulation directs the scope of risk assess-
ment and defines the environmental entities that are
to be protected (termed assessment endpoints) against
a potential stressor. For example, beneficial arthro-
pods are valued ecological entities; abundance within
the agroecosystem is an important attribute; thus
‘‘beneficial arthropod abundance’’ constitutes an
assessment endpoint. Problem formulation further
generates testable scientific hypotheses and endpoints
to measure (termed measurement endpoints) that are
relevant for decision-making and are subsequently
addressed in the analytical phase of the risk assess-
ment (USEPA 1998; Raybould 2006; Carstens et al.
2010; Wolt et al. 2010). Problem formulation should
culminate in a conceptual model delineating how
harm can occur by a particular stressor on the
assessment endpoint (including an analysis of
whether or not exposure to the stressor occurs),
leading to an analysis plan that is consistent with the
risk hypotheses and should establish the relationship
between the stressor and the ecological impacts of
concern. A typical risk hypothesis related to NTA
effects of an arthropod-resistant GE plant is: ‘‘The
expressed protein2 is not toxic to NTAs at the
Table 1 Ranking of types of information and their relative values as evidence (OGTR 2009) (GMO refers to the genetically
engineered organism)
Reliability Appropriateness
Increasing
value
Validated studies conducted according to international
protocols meeting defined standards
Peer reviewed literature—strongly supported reports,
models, theories
Peer reviewed literature—single report, model, theory
General biological principles
Opinion of an expert familiar with the GMO, parent
organism, modified traits, ecology
Other technical reports, specialist literature (for example,
beekeeping), government reports, etc.
No information to indicate a problem
Unsubstantiated statements
Experimental data on the GMO and/or parent
organism in the Australian environment
Experimental data on the GMO and/or parent
organism overseas
Experimental data on modified traits in other
organisms
Experimental data on related, surrogate
systems
2 Although insecticidal traits associated with commercialized
GM crops have all been based on proteins, we recognize that
Transgenic Res (2011) 20:1–22 3
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concentration present in the field’’ (Raybould 2007;
Romeis et al. 2008).3
The risk hypotheses are then addressed in the
analysis phase of the risk assessment following a
tiered framework that is conceptually similar to that
used to assess the environmental impact of conven-
tional chemical plant protection products (Hill and
Sendashonga 2003; Garcia-Alonso et al. 2006; Rose
2007; Romeis et al. 2008). Based on the risk
hypotheses, early-tier laboratory experiments are
conducted under worst-case exposure conditions
where species representative of NTAs present in the
receiving environment that are likely to be exposed to
the arthropod-active protein [referred to as surrogate
species by Caro and O’Doherty (1999)] are exposed
to concentrations of the protein in excess of exposure
in the field. This increases the likelihood of detecting
adverse effects on NTAs (Fig. 1).
Protocols developed to assess the impact of chemical
plant protection products on NTAs have provided a
useful basis for designing similar protocols to assess the
potential effects of GE plants on NTAs (Romeis et al.
2008). They indicate which species may be suitable
surrogates for laboratory studies, describe general
procedures including test system description, organism
preparation, test diets, experimental design as well as
suitable measurement endpoints and quality criteria
such as acceptable control mortalities to adequately
address the assessment endpoint. Available protocols
range between statements of general principles (e.g.,
USEPA 1996a, b) and species specific guidance docu-
ments (e.g., Candolfi et al. 2000; Grimm et al. 2002).
Many of these protocols have been modified to consider
the oral exposure pathway of plant-expressed arthropod-
active proteins, and several protocols of this type have
been described in the literature (e.g., Stacey et al. 2006;
Duan et al. 2002, 2006, 2007).
In some regulatory jurisdictions, early-tier NTA
studies may have to be conducted under the defined
standards of Good Laboratory Practice4 (GLP) which
includes study reconstructability (OECD 1998). The
particular requirements of GLP studies are outside the
scope of this paper and it is advisable for scientists
conducting NTA studies as part of regulatory sub-
missions to ensure that GLP is followed if and as
required by regulatory authorities.
If no adverse effects are seen under the worst-case
exposure conditions in early-tier laboratory studies,
Fig. 1 Risk assessment
continuum. The tiered risk
assessment moves from
tests that have a high ability
to assess adverse effects to
more complex experiments
under field conditions that
evaluate the risks under
more realistic exposure
conditions. Power refers to
the ability to evaluate
adverse effects
Footnote 2 continued
future traits will not be restricted to this class of molecule. For
simplicity we restrict ourselves to arthropod-active proteins.
However, most of the considerations that are described will be
equally applicable for compounds belonging to other classes of
molecules.
3 A second risk hypothesis relevant to NTA risk assessment is
that the transgenic crop does not contain any harmful
unintended changes that may result from the transformation
process. This hypothesis is not addressed in the present paper
since it is generally tested using a range of data that establish
the equivalence and familiarity of the GM plant with its non-
transformed comparators (Romeis et al. 2008; Raybould et al.
2010).
4 Good Laboratory Practice (GLP) embodies a set of principles
that provides a framework within which laboratory studies are
planned, performed, monitored, recorded, reported and
archived. GLP helps assure regulatory authorities that the data
submitted are a true reflection of the results obtained during the
study and can therefore be relied upon when making risk/safety
assessments.
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the risk can be characterized as being acceptable and
there may be no need to conduct any further testing
because of the minimal probability of adverse effects
in the field where NTAs are exposed to much lower
concentrations of the arthropod-active protein. Early-
tier testing thus allows elimination from further
consideration risks that are negligible, and allows
assessors to focus resources to address more signif-
icant risks or uncertainties. If effects are seen under
laboratory conditions at high test substance exposure
concentrations, the risk can be further characterized in
additional laboratory or higher-tier experiments that
use more realistic environmental exposure scenarios
(Fig. 1). Higher-tier studies can include semi-field
tests under enclosed (contained) conditions and open-
field tests, and are sometimes conducted when eval-
uations across multiple trophic levels are warranted or
estimation of population parameters is sought. The
studies may involve the use of population and
community responses and may consider geographic
and temporal variability in exposure to the stressor of
concern. Higher-tier tests are demanding in terms of
skills and resources necessary for their design,
execution, and analysis. Furthermore, results that are
difficult to interpret often do not contribute additional
confidence in the conclusions of the risk assessment.
A recent meta-analysis of published studies on non-
target effects of Bt crops has confirmed that laboratory
studies ‘‘…predicted effects that were on average
either more conservative than or consistent with
effects measured in the field’’ (Duan et al. 2010).
In conclusion, higher-tier tests should only be con-
ducted
1. when triggered by the detection of potentially
adverse effects in lower tiers of testing;
2. when tests at lower tiers are not possible (e.g.,
due to a lack of a testable surrogate or lack of a
validated test protocol);
3. when the nature and mode of action (MOA) of
the arthropod-active protein being evaluated
suggest that the higher-tiered test is most appro-
priate to detect effects.
Selection of surrogate species and life-stages
Since it is not possible to test all species that are
potentially present in the receiving environment and
exposed to the arthropod-active protein, surrogate
species should be selected that represent different
habitats (e.g., soil- or plant-dwelling arthropods) or
different ecosystem services such as ecological func-
tions (e.g., predator, parasitoid or decomposer), and
taxonomic groups. To test the risk hypotheses that
were generated in the problem formulation phase, the
subset of species and life-stages selected for early-tier
testing should be chosen based on the potential
exposure pathway, knowledge on the spectrum of
activity and the MOA of the arthropod-active protein,
the amenability of the test system5 for the selected
NTA, and the availability of the test organism:
1. Exposure pathway. Surrogate species that are
tested should be representatives of those that are most
likely to be exposed to the arthropod-active protein in
the field. There may be considerable knowledge avail-
able on the fate of the protein (e.g., Bt Cry protein) under
field conditions and its movement through arthropod
food-webs (Romeis et al. 2009). Consequently, exper-
iments may not need to be conducted to inform the risk
assessment for species and life-stages that are at
negligible risk because of limited exposure. In the case
of Bt-transgenic crops, an example would be predators
and parasitoids that specifically attack aphids which are
known to contain no or only trace amounts of Bt Cry
protein (Romeis and Meissle 2010). Another example is
the negligible exposure of pollinators or pollen feeders
where there is a lack of protein-expression in the pollen,
for example when the transgene is controlled by a
promoter that does not yield expression in pollen.
2. Known spectrum of activity and mode of action of
the arthropod-active protein. Surrogates and life-
stages need to be selected that are most likely to be
susceptible to the arthropod-active protein and thus are
most likely to detect an adverse effect (i.e., have the
highest predictive power). For example, in the case of
5 OECD (2005) defines ‘‘test system’’ as ‘‘any biological,
chemical or physical system or a combination thereof used in a
study.’’ US EPA 40CFR160 (USEPA 2009) defines ‘‘test
system’’ as ‘‘any animal, plant, microorganism, chemical or
physical matrix, including but not limited to soil or water, or
subparts thereof, to which the test, control, or reference
substance is administered or added for study’’. Test system also
includes appropriate groups or components of the system not
treated with the test, control, or reference substance.
Transgenic Res (2011) 20:1–22 5
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current commercialized Bt Cry toxins, immature holo-
metabolous insects are the only arthropods showing
meaningful susceptibility and neonates are more sensi-
tive than later instars (e.g., Glare and O’Callaghan
2000). When the arthropod-active protein is known to
affect immature development or fecundity in sensitive
arthropods (e.g., target pests), testing of multiple life-
stages or adults, respectively, would be appropriate.
3. Amenability to testing. Species and life-stages
should be selected that are amenable to testing under
laboratory conditions (Rose 2007; Romeis et al.
2008). This includes the availability of experimental
protocols that ensure the interpretability of the data
and the possibility to reproduce or reconstruct the
study. Experience with the testability of a species or a
specific life-stage comes, for example, from NTA
testing of pesticides and from previous studies with
orally active proteins. Different life-stages of a
particular arthropod species (e.g., Meissle and Romeis
2009b) or of taxonomically-related species (e.g.,
Heimbach et al. 2000a) might differ substantially in
their amenability to testing in the laboratory due to
their specific biology, lifespan, required diet, etc.
4. Availability of the test arthropod. For pesticide
testing, the IOBC/WPRS, European Plant Protection
Organisation (EPPO) and Beneficial Arthropod Reg-
ulatory Testing Group (BART) have recommended
using laboratory-reared arthropods (Barrett et al. 1994;
Candolfi et al. 2000, 2001). Standardized test arthro-
pods from public sector or commercially reared
laboratory colonies provide a level of consistency
between experiments (due to an overall similar genetic
susceptibility) and testing laboratories that promotes
data reproducibility and comparability. Although
some phenotypic differences from wild populations
may occur during laboratory breeding, such limita-
tions are deemed preferable to the unknown and
variable condition of field-collected specimens (e.g.,
previous exposure to the test substance, variable age
and health status). Although not recommended, when
there is not a viable alternative and field-collected
NTAs must be used, specimens should be standardized
as much as possible and information on the site and
method of collection as well as details on the handling
and maintenance between the time of collection and
use in the experiments should be provided (e.g.,
Heimbach et al. 2000a, b).
Test substance
The test substance should be characterized and
formulated in a way that allows precise calculation
of the amount that is delivered to the test organism.
Test substance characterization and equivalence
Relevant properties of the test substance such as
physical state, color, consistency, and pH should be
described. Before starting an experiment, the follow-
ing should be known about the test substance, which
is typically either in a purified form or GE plant
material expressing the protein of interest:
1. Biological activity of the test substance. Test
substances should be in a formulation that ensures
biological activity. Bioactivity should be confirmed
using relevant assays like sensitive insect bioassays
(e.g., Duan et al. 2006, 2008a; Stacey et al. 2006;
Meissle and Romeis 2009a), biochemical assays in
case of enzyme inhibitors (e.g., Shade et al. 1994), or
agglutination assays in case of lectins (e.g., Van
Damme et al. 1987).
2. Purity of the test substance. The purity of the test
substance needs to be known to calculate the true dose
and amount that is delivered to the test organism. The
active ingredient(s) and relevant impurities must be
identified and quantified within technically feasible
limits and the method(s) applied to determine purity
must be stated.
3. Test substance equivalence (e.g., for purified
protein). The arthropod-active protein provided to
test organisms may be derived from GE plants or, more
commonly, produced as recombinant protein in micro-
bial expression systems. The concentration of the
introduced protein in transgenic plant tissues can be
very low, often less than 0.01% on a dry weight basis.
Early-tier studies (and other toxicology studies such as
those used to assess GE food safety) that require
relatively large amounts of test substance are often not
feasible using plant-expressed protein as sufficient mass
cannot be reasonably purified from the plant source
(CAC 2003). Instead, these studies normally make use
of protein purified from bacterial or yeast expression
systems. In such cases, it is necessary to demonstrate
functional and biochemical equivalence (i.e., equivalent
physiochemical properties and biological activities) of
6 Transgenic Res (2011) 20:1–22
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the plant and microbial purified proteins (Gao et al.
2004, 2006; Raybould and Vlachos 2010). For example,
comparisons of the molecular weight, the isoelectric
point, amino-acid sequence, post-translational modifi-
cations including glycosylation patterns, immunologi-
cal reactivity, biological activity, and in the case of
enzymes, the enzymatic activity, may be needed to pro-
vide evidence for the equivalence (EFSA 2008; USEPA
2000, 2001). For Cry and vegetative insecticidal pro-
teins (VIP) from Bacillus thuringiensis, fully character-
ized purified proteins have been successfully produced
for use in NTA studies (Gao et al. 2004, 2006; OECD
2007; Raybould and Vlachos 2010), but this may not
always be possible for future arthropod-active proteins.
Test substance stability and homogeneity
To ensure consistent exposure to the test substance
over the course of a laboratory study, its stability has
to be ensured or the diet into which it has been
incorporated has to be replaced from a characterized
batch at regular intervals. Where the test substance
has been incorporated into a diet, its concentration
should be monitored and recorded throughout the test
period. Immuno-assays such as enzyme-linked immu-
nosorbent assay (ELISA) to measure protein concen-
tration, Western blot analysis to measure protein
intactness, and/or sensitive insect bioassays to mea-
sure bioactivity (Duan et al. 2002, 2006, 2008a;
Stacey et al. 2006; Raybould and Vlachos 2010) may
be employed. Stability should be defined based on the
variability of the assay used. For example, for some
ELISA methods, stability may be defined as [70%
of initial concentration. Stability criteria should be
defined prior to study initiation and should consider
limitations of the immunoassays, insect bioassays, or
effects of reagents and buffers on the test substance. In
general, the following principles should be followed:
1. The test substance (or a diet medium into which it
has been incorporated) should be stored under
conditions that maintain its intactness and activity.
Note that freeze–thaw cycles may be detrimental to
some substances, especially proteins. If this is the
case, very short harvest-to-analysis intervals must
be used or other storage conditions must be devised.
2. The batch of the test substance tested should
preferably be the same throughout the duration of
the experiment.
3. If it is not possible to use the same batch throughout
the experiment, a new batch of test substance can
be used as long as it is fully characterized.
4. If the stability of the test substance cannot be
guaranteed for the duration of the study, freshly
treated diet should be supplied periodically (e.g.,
daily).
Appropriate assays should be performed to ensure
the storage stability of the test substance during the
experiment. For example, a sub-sample of the test
substance should be stored under the same conditions
(e.g., sub-freezing temperatures) as the samples that
are used in the experiment, and analyzed at the end of
the storage period.
If the test or control substance is incorporated into a
diet, testing must confirm that the method of mixing
results in the expected concentration of the protein and
that the test substance is homogenously distributed in
the diet. This determination should occur prior to the
start of the study or concurrent with it. Homogenous
distribution of the test substance is important to rule
out that individual test organisms are able to avoid the
test substance altogether or are exposed to lower than
anticipated levels while others might be over-exposed.
Homogeneity of the diet is typically tested by analyz-
ing sub-samples of the diet (e.g., Duan et al. 2006,
2008a). Homogeneity criteria, as with stability criteria,
should be defined prior to study initiation and should
account for assay limitations. Similarly, it needs to be
known to what extent the test substance activity
degrades at different times during the experiment in
order to calculate the actual dose delivered. One could
refer to published studies when available. For exam-
ple, when Bt maize pollen is used as a carrier to expose
NTAs to a Cry protein, ELISA analyses may be
sufficient to establish the concentration if stability has
been previously established under relevant environ-
mental conditions (Wraight et al. 2000; Hellmich et al.
2001; Stanley-Horn et al. 2001; Meissle and Romeis
2009a).
Method of delivery (carrier)
When the test substance is expected to act by a dietary
route, the test substance must be delivered orally. To
date, this has been true for all plant-expressed
arthropod-active proteins. The method of delivery of
the test and control substances should be selected to
Transgenic Res (2011) 20:1–22 7
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ensure maximum accuracy of the dose administered.
It needs to be established that the chemical and
biological properties of the test substance are not
altered when incorporated into a carrier (see also
above section on ‘‘Test substance stability and
homogeneity’’). In addition, appropriate controls must
be added to the study design to differentiate effects
that are related to the carrier and those that are related
to the test substance (see also below section on
‘‘Control substances’’). In all cases, potential effects
of the carrier must be accounted for in the experiment.
Different methods for delivery of test substance can
be applied with the following considerations:
1. Artificial diet. In most cases the purified protein
or GE plant material is provided to the test organism
in artificial diet. When purified arthropod-active
protein is used as the test substance it needs to be
dissolved in water or buffer and the characteristics of
the solvent must be provided. The science and
technology of arthropod diets can be complicated
(Cohen 2004). Since the diet can directly and/or
indirectly impact study quality and study results, the
diet is a key element to consider in study design.
Since most arthropod diets are meridic (only partly
defined chemically), care must be taken that the diet
constituents themselves do not adversely interact with
test substances. Diets may be species-specific, as
determined by the nutritional requirements and the
feeding habits of the test NTA. The test substance
should be incorporated into the diet in a homogenous
manner, or used as a diet overlay, permitting the
arthropods to ingest the protein during feeding. In any
case, a detailed description of such procedures should
be provided. Care must be taken to ensure the test
substance is not affected when it is incorporated into
the diet (e.g., by heat deactivation).
Artificial diets have successfully been used to test
the effects of purified arthropod-active proteins on a
range of arthropods, including: larvae of Aleochara
bilineata (Coleoptera: Staphylinidae) (Stacey et al.
2006), larvae of Poecilus chalcites (Coleoptera:
Carabidae) (Duan et al. 2006), nymphs of Orius
insidiosus (Heteroptera: Anthocoridae) (Stacey et al.
2006), adult Chrysoperla carnea (Neuroptera: Chrys-
opidae) (Li et al. 2008), and adult and larvae of Apis
mellifera (Hymenoptera: Apidae) (Malone et al.
1999; Brødsgaard et al. 2003). Particularly notewor-
thy are current efforts to standardize artificial-diet
based in vitro feeding methods to test A. mellifera
larvae (Aupinel et al. 2007, 2009; CDPR 2009).
2. Treatment of non-GE food items. In cases when
no artificial diet is available, alternative ways to dose
the test organisms with the purified protein can be
applied. For example, the test substance may be
dissolved in appropriate surfactants and applied to
non-GE plant material. This has been done with leaves
to expose foliar-feeding arthropods (Chen et al. 2008).
Similarly, non-GE pollen has been treated with
solution in which the test protein was dissolved
to dose predators such as Coleomegilla maculata
(Coleoptera: Coccinellidae) (Duan et al. 2002) or
O. insidiosus (Duan et al. 2007, 2008a), and bees such
as A. mellifera (see references in Duan et al. 2008b)
and Osmia bicornis (Hymenoptera: Megachilidae)
(Konrad et al. 2008). Alternatively, the predatory
beetles Coccinella septempunctata (Coleoptera: Coc-
cinellidae) and Poecilus cupreus (Coleoptera: Cara-
bidae) have been exposed to test substances by
dipping their prey into toxin-containing solution or
by injecting their prey with the solution, respectively
(Stacey et al. 2006). Another option exists in dosing
the test organisms with test substances dissolved in a
sugar-rich solution (honey or sucrose). This method is
commonly used to dose adults of parasitic Hymenop-
tera that are known to feed on carbohydrate sources in
the field (Romeis et al. 2003a; Bell et al. 2004;
Hogervorst et al. 2009) but also for larvae of predatory
arthropods including C. carnea, C. septempunctata
and Adalia bipunctata (Coleoptera: Coccinellidae)
(Hogervorst et al. 2006; Lawo and Romeis 2008;
A´lvarez-Alfageme et al. 2010).
3. GE plant material. GE plant material containing
the arthropod-active protein can be used as the test
substance when it is regarded as the stressor of
concern or in situations where the test organism
cannot be fed on an artificial diet or where no purified
protein is available. The study conductor must be
aware of the fact that there is also the possibility of
carrier effects; in other words, there may be differ-
ences between the treatment and control unrelated to
the arthropod-active protein and related to the effect
of different carriers, for example due to different
genetics or environments under which the GE plants
were grown (see Escher et al. 2000; Wandeler et al.
2002; Jensen et al. 2010; Knecht and Nentwig 2010
for examples).
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For example, larvae of the monarch butterfly,
Danaus plexippus (Lepidoptera: Danaidae), could not
be reared reliably to adult on an artificial diet, so
milkweed leaf discs (Asclepias curassavica) dusted
with varying amounts of Bt maize pollen grains were
used to estimate pollen/Cry protein effects (Hellmich
et al. 2001; Dively et al. 2004). Similar studies have
been conducted with larvae of other Lepidoptera
species (Wraight et al. 2000; Jesse and Obrycki 2002;
Shirai and Takahashi 2005; Li et al. 2005).
Bt maize pollen may also be used as a carrier to
expose predatory arthropods that readily consume this
plant tissue under field and laboratory conditions.
Species that have successfully been exposed this way
include: larvae and adults of A. mellifera (see refer-
ences in Duan et al. 2008b), C. maculata (Coleoptera:
Coccinellidae) (Duan et al. 2002; Lundgren and
Wiedenmann 2002), Propylea japonica (Coleoptera:
Coccinellidae) (Bai et al. 2005), adult C. carnea
(Li et al. 2008), immature and adult Neoseiulus
cucumeris (Acari: Phytoseiidae) (Obrist et al.
2006c), and juvenile spiders (Araneae) (Ludy and
Lang 2006; Meissle and Romeis 2009b). Furthermore,
GE plant litter is commonly used to study impacts on
soil arthropods that play a role as decomposers such as
Collembolans (Yu et al. 1997; Romeis et al. 2003b;
Heckmann et al. 2006) and mites (Yu et al. 1997).
The use of GE plant material may prevent testing
of the arthropod-active protein under worst-case
exposure conditions in excess of that found in plant
material since the test arthropods can only consume
the concentration of the active protein contained in
the plant tissue. However, since the diet of NTAs is
unlikely to consist of 100% GE crop tissue in the
field, studies using plant tissue can still provide very
conservative exposures (see also below section on
‘‘Concentration/dose selection’’).
4. GE plant-fed herbivores. Herbivores that have
fed on GE plant material and are subsequently shown
to contain bioactive toxin may be used as carriers to
deliver the arthropod-active protein to entomophagous
arthropods (tri-trophic exposure). Great care should be
taken to ensure that the herbivores themselves are not
adversely affected by the ingested protein so as to
avoid the impact of prey/host-quality mediated effects
(Romeis et al. 2006; Naranjo 2009). One such carrier
that has successfully been used is Bt maize-fed spider
mites (e.g., Dutton et al. 2002; Li and Romeis 2010;
A´lvarez-Alfageme et al. 2008, 2010). These herbi-
vores have been shown to contain high concentrations
of Bt protein which are similar to concentrations
measured in the leaves on which they have fed (Obrist
et al. 2006a, c; Torres and Ruberson 2008; Meissle and
Romeis 2009b; Li and Romeis 2010; A´lvarez-Alfa-
geme et al. 2008, 2010). Furthermore, sensitive insect
bioassays have shown that Cry proteins contained in
spider mites after feeding on Bt maize retain their
biological activity (Obrist et al. 2006b; Meissle and
Romeis 2009a). The bioactivity of Bt Cry proteins
following ingestion of Bt maize has also been
confirmed for larvae of Ostrinia nubilalis (Lepidop-
tera: Crambidae) (Head et al. 2001; Obrist et al. 2006b)
and adult Diabrotica virgifera virgifera (Coleoptera:
Chrysomelidae) (Meissle and Romeis 2009a).
Another potential carrier of the test substance is a
strain of the target organism that is resistant to the
particular arthropod-active protein. For example,
strains of Plutella xylostella (Lepidoptera: Plutelli-
dae) and Helicoverpa armigera (Lepidoptera: Noc-
tuidae) that are resistant to specific Bt Cry proteins
have been used to assess toxin effects on predators
and parasitoids (Schuler et al. 2003, 2004; Ferry et al.
2006; Chen et al. 2008; Lawo et al. 2010). Recently,
Lawo et al. (2010) measured the Cry1Ac concentra-
tion in neonate H. armigera after 24 h feeding on Bt
(Cry1Ac) cotton. Larvae from a Cry1Ac-resistant
strain contained four times more toxin per gram fresh
weight when compared with larvae from a susceptible
strain. Resistant larvae in tri-trophic studies can thus
be used to expose their natural enemies to higher
concentrations of the toxin when compared with the
natural situation in the field. However, care must be
taken to ensure that the ingested protein in the
resistant insects is still active (Chen et al. 2008).
Concentration/dose selection
As part of the environmental risk assessment, an
exposure characterization is performed to determine
how much of the arthropod-active protein a particular
organism might be exposed to in the field under
natural conditions (the expected environmental con-
centration, EEC). In general, secondary exposure of
arthropod predators and parasitoids through herbiv-
orous prey or hosts is generally lower than direct
exposure of plant-consuming arthropods. Since in the
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majority of cases precise estimates of the concentra-
tions of the arthropod-active protein in the natural
diet of the NTA are not possible, conservative
assumptions must be made. For this purpose, the
highest average concentration of protein measured in
the plant tissue over the course of growth develop-
ment is typically taken as the worst-case EEC (e.g.,
Rose 2007; Raybould et al. 2007; Raybould and
Vlachos 2010). Defining the highest average plant-
expression level as the EEC adds to the conservatism
of the assessment since (a) the NTAs may not
exclusively consume GE plant tissue, and (b) plant-
produced arthropod-active proteins are usually
diluted in the natural food web. This dilution effect
has been reported for Bt crops (e.g., Harwood et al.
2005; Obrist et al. 2006a; Meissle and Romeis 2009b)
but has also become evident from tri-trophic labora-
tory studies with other arthropod-active proteins (Bell
et al. 2003; Christeller et al. 2005). Nevertheless,
some cases exist where the EEC has been defined
more precisely taking into account knowledge on the
NTA’s feeding behaviour. For example, consumption
of maize pollen has been quantified in some detail for
larvae of A. mellifera (Babendreier et al. 2004), adult
C. carnea (Li et al. 2010) and adult C. maculata
(Lundgren and Wiedenmann 2004; Lundgren et al.
2005). The EEC can thus be based on pollen
expression levels (if the arthropod-active protein is
present in pollen) since consumption of this plant
tissue is the main (if not only) source of exposure to
the plant expressed protein.
In practice, NTA studies are often conducted at
times when plant expression levels for the event that is
going to be commercialized are not fully characterized.
Therefore, studies are often conducted at the highest
possible concentration of the test substance that can be
delivered with the test system. One has to be aware, that
these high doses may eventually cause an effect which
would then trigger additional studies including, for
example, dose–response tests to assess accurately the
effect relative to the EEC, which, as mentioned
previously, depends on plant-expression levels.
Early-tier tests are often conducted as single dose
tests, for instance, at the so-called maximum hazard
dose (MHD). The MHD is calculated by multiplying
the EEC with a margin of exposure factor (e.g., US
EPA suggests a MHD margin of exposure factor of
109). In cases where a high excess dose is not
achievable (e.g., because GE plant material is used as
the test substance), the actual maximum dose to
which the test organism is exposed should be reported
and the reason for the testing dose selection stated.
The MHD margin of exposure factor adds certainty to
the conclusions drawn from the test and accounts for
possible intra- and interspecies variability from the
use of a surrogate species. Studies that establish a
lack of adverse effects at the MHD level are sufficient
to confirm the absence of unacceptable adverse
effects, making lower dose testing unnecessary.
For studies establishing an LC50, LD50, EC50, or
ED50 value the number of doses and test organisms
evaluated must be sufficient to determine accurate
values, and when necessary or required, the Lowest
Observed Adverse Effect Concentration (LOAEC),
or No Observed Adverse Effect Concentration
(NOAEC). If the LC50, LD50, EC50, or ED50 values
are greater than the MHD (e.g., LD50 [ 109 EEC),
then those data are sufficient to inform the risk
assessment, and lower dose testing is unnecessary. If
the values are less than the MHD used, additional
testing with lower doses may be required.
An estimation of risk is often made by comparing
the LOAEC or NOEC to the EEC; when the EEC is
lower than the LOAEC or NOEC, a conclusion of
‘reasonable certainty of no adverse effects’ can be
made (e.g., Raybould et al. 2007; Raybould and
Vlachos 2010).
For studies using GE plant tissues as the test
substance, a factor of 19 or less is used and a margin
of exposure of greater than one may not be possible
due to the limited expression of the arthropod-active
protein in the plant. A 19 plant concentration of the
protein may thus be most relevant when the actual
exposure to the species of interest in the field is known
to be much lower that the concentration of the novel
protein in the plant tissue, for example, if a test
organism is forced to ingest green plant tissue, but in
the environment the organism feeds on decomposing
senesced tissue. For some arthropod species, exposure
to the test substance can be enhanced when test
organisms are exclusively fed with plant or arthropod
material containing the protein of interest that would
otherwise constitute only part of their diet in the field
or by using lyophilized plant powder as test substance.
Examples include ladybird beetles that use maize
pollen as complementary food in the field or generalist
predators that occasionally consume spider mites as
part of their prey spectrum. Feeding these species with
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either a high proportion, or even exclusively with GE
maize pollen or GE plant-fed spider mites, would
constitute worst-case exposure. Examples are tests in
which larvae or adults of C. maculata are fed large
amounts of GE maize pollen mixed with insect eggs
(Duan et al. 2002; Lundgren and Wiedenmann 2002),
studies in which A. mellifera receive only GE maize
pollen (Rose et al. 2007), or the feeding of predom-
inately aphidophagous A. bipunctata or C. carnea
larvae exclusively with spider mites that have fed
exclusively on transgenic plant material (Dutton et al.
2002; A´lvarez-Alfageme et al. 2010).
Measurement endpoints
Prior to testing, the objectives of the individual study
need to be defined, and specific measurement end-
points (also known as measures of effect) described
that test the identified risk hypotheses. Appropriate
measurement endpoints should be easy to evaluate in
the laboratory and likely to indicate the possibility of
adverse effects on the abundance of NTAs or other
assessment endpoints. Thus, priority should be given
to measurement endpoints for which it is clear what
change constitutes an adverse effect.
Typical measurement endpoints to address NTA
effects of plant protection products and arthropod-
active proteins that are expressed in GE plants are
mortality (e.g., estimated as LD50), fecundity, devel-
opment duration, body mass (as a measure of growth),
or the percentage of individuals that reach a certain
life-stage (e.g., percent adult emergence) (Candolfi
et al. 2000; Rose 2007; see Stacey et al. 2006 and
Duan et al. 2002, 2006, 2008a for sample protocols).
Independent from the measurement endpoints that are
selected for a specific study, risk assessors should
agree on how to interpret and use these data in the risk
assessment. This includes the definition of thresholds
that trigger additional testing. Similar to the assess-
ment of pesticides (Candolfi et al. 2000) an effect size
of 50% mortality has been defined as the threshold to
trigger additional tests for early-tier laboratory studies
conducted under worst-case exposure conditions with
purified arthropod-active protein or GE crop tissue in
the USA (USEPA 1998; Rose 2007). Less than 50%
mortality under these conditions of extreme expo-
sure suggest that population effects are likely to be
negligible given realistic field exposure scenarios.
Furthermore, once the threshold is defined it should be
ensured that the experiment is sufficiently replicated
to detect the defined effect size with acceptable
statistical power (see also section below on ‘‘Statis-
tical considerations’’).
Determination of the measurement endpoint(s)
should consider knowledge about the impact of the
arthropod-active protein on the target organisms and
its MOA, knowledge about the biology of the
selected NTA species and life-stages, and the avail-
ability of reliable test protocols. The measurement
endpoint(s) selected will affect the duration of the test
(see section below on ‘‘Test duration’’). For example,
the current arthropod-active proteins in GE crops
(Bt Cry and VIP proteins) are lethal to sensitive
(target) species. Thus, mortality is one obvious
measurement endpoint for laboratory NTA studies.
In the case of arthropod-active proteins that are
known to cause sublethal effects on sensitive arthro-
pods (such as reducing the fecundity or delaying
development), these parameters should receive atten-
tion and be measured when assessing the impact on
NTAs. This is the case for some inhibitors that affect
the arthropod’s digestive system and lectins. Several
endpoints may need to be measured for arthropod-
active proteins for which limited experience regard-
ing their impact on arthropods exists.
Besides the described measurement endpoints, any
other sublethal effects that are observed during the
experiment (e.g., changes in behavior) should be
recorded. Subsequently, risk assessors may agree that
the observed effects trigger additional testing. How-
ever, observations of apparent sub-lethal effects may
need to be interpreted with caution and always
compared with the negative control(s), since rearing
arthropods on a sub-optimal diet medium may itself
cause unforeseen side-effects on their subsequent
reproductive vigor.
Test duration
In general, laboratory tests are shorter in duration than
semi-field or field studies but are conducted at higher
protein doses/concentrations. The duration of a spe-
cific laboratory test depends largely on the endpoints
that are measured, i.e., the duration of the test must be
sufficiently long for the measurement endpoint to
respond should the test substance have an adverse
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123
effect. The duration of an experiment is further
determined by the selected surrogate and its life-
stages, their rate of development under the specific
experimental conditions (incl. experimental set-up,
environmental conditions), the suitability of the test
system, and the characteristics of the test substance.
1. Measurement endpoint. The duration required to
measure a certain endpoint depends on the endpoint
chosen. In general experiments that focus on the
organism’s developmental stages and measure, for
example, mortality or days to adult emergence can
vary from 14 to more than 30 days depending on the
species, while for example tests measuring the
fecundity of A. bilineata last for 11 weeks (Grimm
et al. 2000; Stacey et al. 2006; Raybould et al. 2007;
Raybould and Vlachos 2010). For comparison, tests
that assess mortality as a response to treatment with
chemical pesticides can be substantially shorter (e.g.,
2 days in the case of adult honeybees, USEPA 1996c).
2. The selected surrogate and its life-stages. The
duration of the experiment depends on the test organ-
ism’s biology and in particular its rate of development
under the specific experimental conditions. For exam-
ple, developmental time until adulthood is shorter for
Orius species (Stacey et al. 2006; Duan et al. 2007)
than for Poecilus species (Duan et al. 2006; Stacey
et al. 2006).
3. Suitability of the test system. To ensure the
reliability of the obtained results, test organisms
should not show unacceptably high mortalities in the
negative controls. This ensures that potential back-
ground effects (including quality of the test organisms
and the suitability of the test system and environmental
test conditions) were negligible and did not affect the
observed treatment effects. Principles of basic toxicity
testing dictate that test organisms should be healthy
and of high quality and not otherwise stressed by
factors other than the stressor in question (i.e., the
arthropod-active protein) (Klaasen 2001). Therefore,
negative control thresholds (e.g., maximum mortality
or minimum fecundity) are generally defined for a
specific organism and test protocol above which test
results should be discarded (see also below section on
‘‘Control substances’’). In general, a study should be
terminated if control mortality exceeds a pre-defined
threshold. That may mean that data are not used, or that
the only data used are those prior to the control
mortality being exceeded. Whether to use those data
will depend on the guideline being followed and when
the control mortality criterion was exceeded. For
example, if the criterion is exceeded after 21 days, it
may be acceptable to draw reliable conclusions from
the data for day 20 (e.g., if one is working with a Bt
protein that is known to have effects on susceptible
insects after 5 days); on the other hand, if the criterion
is exceeded after 3 days, the study should be started
again.
4. Characteristics of the test substance. Knowledge
available on the impact of the test substance on a
range of sensitive target organisms should be con-
sidered to demonstrate the spectrum of activity. For
example, it has been recommended that test durations
for Bt Cry proteins should be a minimum of 5 days,
but preferably 7–14 days, in light of the time period
for the proteins to demonstrate toxicity against some
target pests (Rose 2007).
One should note that the period during which the
test organism is actually exposed to the test substance
can be shorter than the observation period (i.e., the
duration of the experiment). One example is the
honey bee larval test. In the bee test, young larvae are
dosed with test substance in their brood cell only
once at the start of the experiment, and adult
emergence is measured after about 18 days (see
references in OECD 2007). Another example is the
protocol established to assess fecundity of A. bilineata
(Grimm et al. 2000; Stacey et al. 2006) where adult
beetles are treated with the test substance and
provided with fly pupae to lay their eggs (the larvae
develop parasitically within the fly pupae). After
removal of the treated beetles, the fly pupae are
monitored for a further 6 weeks to record the number
of emerging second-generation beetles.
Control substances
Negative controls
The reason for using negative controls is to assess the
natural background effects on the measurement end-
points within the test system. The inclusion of negative
controls allows an assessment to be made of how the
test system and test conditions, including the carrier,
are influencing the mortality, development, and/or
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behavior of the non-target arthropod tested. Thus,
negative controls assist in determining whether the
observed effects are related or not to the treatment.
When choosing the appropriate negative control
treatment, it is important to consider the potential
effects of the diet (or any other carrier) in which the
test substance is delivered. Sometimes several neg-
ative control diets may be required. For example, in
simple test diets, such as sugar solutions to which
high concentrations of a protein test substance have
been added, the inherent nutritional value of the test
substance can affect the test results. In such cases, it
may be appropriate to not only include an untreated
control diet treatment but also to amend the negative
control diet with an inert or heat-deactivated supple-
ment such as bovine serum albumin to ensure
nutritional equivalence (Brødsgaard et al. 2003; Bell
et al. 2004).
The choice of the appropriate negative control is
particularly critical when GE plant material is used to
deliver the test substance. For GE plant material,
typically material of the unmodified (non-trans-
formed) near-isoline is used as the negative control
in order to rule out effects of variability in plant
composition on defined measurement endpoints.
Genetic variation across plant varieties can cause
differences in a range of plant compounds (e.g.,
Ridley et al. 2002; Zurbru¨gg et al. 2010), that may
affect non-target organisms (e.g., Escher et al. 2000;
Wandeler et al. 2002; Jensen et al. 2010; Knecht and
Nentwig 2010). These differences are part of the
normal variation in a crop. Consequently, it may be
necessary to add several negative control reference
lines to establish the normal response variation of the
test NTA in the crop. This allows the assessor to set
any observed effects into context.
The mortality observed in the negative control
treatment group is a strong indicator of whether or
not an appropriate study design has been used.
Acceptable control mortalities need to be defined
for any specific test as has been done for the
standardized protocols for the acute testing of plant
protection products (e.g., Candolfi et al. 2000). For
example USEPA guidelines (USEPA 1996b) suggest
terminating the test when control mortalities rise
above 20% (Rose 2007). It has been recognized that
higher control mortalities are expected and might be
acceptable where assessment of arthropod-active
proteins is required across multiple life-stages of
the test organism, thus requiring longer test durations
(Romeis et al. 2008). In any case, Abbott’s correction
(Abbott 1925) should be applied to correct the
treatment results for the mortality observed in the
negative control group, and both corrected and
observed mortality should be reported.
Positive controls
Positive control compounds are particularly useful for
test protocol development and standardization (e.g.,
Duan et al. 2007). They may also be required for
regulatory early-tier studies since they fulfill specific
roles (see below). Consequently, the selection of appro-
priate positive controls requires careful consideration.
In general, positive controls and test substances should
have similar properties in terms of their route of toxicity
(e.g., oral versus dermal) and behavior-modifying
properties (e.g., repellent or anti-feedant properties).
There are several purposes of positive control
treatments:
1. Determine whether or not the test substance was
actually ingested. For this purpose any orally-active
arthropod toxin can be used as a control. These control
substances need to be provided to the test organisms in
a similar way (i.e., in an artificial diet) as the test
substance. Effects observed in the measurement end-
points indicate that the control substance has been
ingested and thus provide indirect evidence for the
ingestion of the test substance. Examples are stomach
poisons such as the growth regulator teflubenzuron
(Stacey et al. 2006), potassium arsenate (Duan et al.
2006, 2007), or the proteinase inhibitor E-64 (Duan
et al. 2007). Alternatively, ingestion of test substance
could also be confirmed by immuno-assays (e.g.,
ELISA test) of the treated arthropods (Vojtech et al.
2005; Li et al. 2008; Chen et al. 2009; Meissle and
Romeis 2009b; Li and Romeis 2010; A´lvarez-
Alfageme et al. 2010) or their frass (Brandt et al.
2004; Christeller et al. 2005; Mulligan et al. 2010), by
incorporation of a dye into the prepared diet and
subsequent examination of the diet uptake (Rodrigo-
Simo´n et al. 2006), by labeling the protein of interest
with a fluorescent compound such as rhodamine and
confirm its uptake by the test organisms (Hogervorst
et al. 2006), or by simply determining the weight of the
test arthropods prior to and after exposure to the test
substance (Romeis et al. 2004; Li et al. 2008).
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2. Proof that the test system works (demonstrate that
the test system is able to detect treatment effects).
Positive control compounds can be selected and their
concentrations adjusted to show that the defined
effect sizes are detectable within the experimental
set-up. For example, snowdrop lectin has been used
to determine whether sublethal effects on develop-
ment time and fecundity can be detected (Lawo and
Romeis 2008; Li et al. 2008; A´lvarez-Alfageme et al.
2010). Such carefully selected positive controls may
thus replace statistical power analyses and effect size
calculations since they provide evidence that the
effect of interest would have been detectable.
3. Allow comparison to other test results. Positive
controls may function as useful references to permit
comparison of experiments that have been conducted
previously (e.g., to establish the sensitivity of the
NTA and to establish validity of the assay), or across
multiple laboratories.
Statistical considerations
Consultation with a skilled statistician conversant in
environmental toxicology testing before an experi-
ment is conducted should eliminate most common
design problems. Appropriate statistical methods and
statistical power, i.e., the probability of finding a
difference that does exist, must be employed to reach
meaningful conclusions.
Ideally, sample size calculations should be com-
pleted prior to the start of the experiment. This should
be done to ensure that the assay is sufficiently
replicated to detect a pre-defined effect size (e.g.,
50% used by US EPA, Rose 2007) with appropriate
statistical power (e.g., Duan et al. 2006, 2008a). A
level of 80% power at an alpha level of 0.05 is usually
considered acceptable (Rose 2007; Perry et al. 2009).
Alternatively, retrospective power analyses may be
conducted on non-significant results after a study has
been completed (Steidl et al. 1997; Thomas 1997;
Hoffmeister et al. 2006). For example, using the
recorded mean and standard deviation of the negative
control treatment and the true sample sizes tested in a
particular study, one can calculate (a) the difference
between the treatment and negative control that would
have been detectable (given that a = 0.05 and a power
of 80%), or (b) the power achieved for a defined
detectable difference (e.g., a 20% effect) (e.g., Marvier
2002; Lundgren and Wiedenmann 2002; Li et al. 2008;
Meissle and Romeis 2009b).
The following statistical approaches are com-
monly used in laboratory non-target testing. For
MHD tests, analysis of variance (ANOVA) and
proportion tests (z test) are suitable (Candolfi et al.
2000; Rose 2007). If a threshold of activity is used as
the criterion to trigger higher-tier tests (e.g., C50%
mortality), then proportion tests can be used to
directly evaluate if the experimental result observed
when the NTA is exposed to a limit dose is
significantly lower than this threshold. Since the null
hypothesis, in this case, is that the experimental result
is greater than this threshold (assuming control
mortality criteria are met), rejection of the null
hypothesis at a given alpha level, typically 0.05,
provides 95% power in the conclusion that a result is
less than the threshold (Rose 2007). One-sided tests
may be appropriate for such considerations. For
proportion testing, use of an alternative null hypoth-
esis may also be acceptable. For cases where a
threshold is not established, e.g., growth or repro-
duction endpoints or studies using plant material, use
of ANOVA to compare treatment and the relevant
comparator (control) may be most appropriate (Chap-
man et al. 1996). For dose-response studies, probit
analysis, generalized probit analysis, logistic regres-
sion, and moving average-angle methods are suitable
(Grimm et al. 2001). The robustness of the results
should be documented by providing the 95% confi-
dence or fiducial limits and the statistical significance
of the fit of the data to the regression model.
See also for additional statistical advice and for
guidance concerning the choice of testing procedures:
guidance documents published by EPPO (EPPO 2007),
the Society of Environmental Toxicology and Chem-
istry (SETAC) (Chapman et al. 1996), and the US
Environmental Protection Agency (USEPA) (Rose
2007).
Conclusions
A sound environmental risk assessment is essential to
evaluate the likelihood and seriousness of harm to
NTAs that may result from cultivation of a GE
arthropod-resistant crop. In such assessments, it is
necessary to test for the potential of the arthropod-
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active protein to have adverse effects on NTAs.
Effective assessment of adverse effects follows a
tiered approach that starts with laboratory studies
under worst-case exposure conditions; such studies
have a high ability to detect adverse effects on non-
target species. As not all NTAs can be tested, early-
tier laboratory studies should accurately determine
the effects on surrogate non-target arthropods
(selected depending on the scope of the risk assess-
ment) of known concentrations of the test substance.
In most cases, the test substance will be a purified
protein produced in microbial expression systems, or,
alternatively, GE plant tissue.
Good study design seeks to minimize the proba-
bility of erroneous results: false negatives—the
failure to detect adverse effects of substances that
are potentially harmful in the field, and false
positives—the detection of adverse effects when the
substance is unlikely to be harmful in the field. Thus,
reliable test systems should adhere to relevant test
protocol design criteria to avoid erroneous results
(Box 1). Such erroneous results may arise if the
conduct of the test introduces bias, or exposes the test
NTAs to conditions that are significantly different
from those under which the test is known to be
reliable. Because some regulatory jurisdictions
require that early-tier NTA studies be conducted
under GLP, scientists conducting NTA studies as part
of regulatory submissions should first determine if a
GLP requirement exists.
Confidence in a conclusion of no adverse effect
on a species (i.e., the avoidance of false negatives),
and confidence in extrapolating that conclusion to
other species, depends upon the ability of the study
to detect such effects. Adhering to the principles
and recommendations outlined in this paper should
increase confidence in the results of early-tier
laboratory studies, and thereby reduce data require-
ments for stressors that pose low risk. If adverse
effects are detected in such studies, the results
should be easier to interpret and higher-tier studies
for GE crops producing those substances can be
designed.
The recommendations and associated guidance
elaborated in this document thus provide a sound
scientific foundation for experimenters conducting
early-tier NTA tests. These will also facilitate the
reproduction of a study, peer review of such tests by
others in the scientific community, and will benefit
regulatory authorities by enhancing the quality of
information generated for use in risk assessments.
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Box 1 Study design criteria for NTA laboratory studies
(a) The test substance must be well characterized and
described. This includes the source and purity of the
arthropod-active protein, and its stability and homogeneity
in the carrier through which it is provided to the test
organism
(b) The test substances must be biochemically and
functionally equivalent to the protein or other active
ingredient produced in the GE crop
(c) The bioactivity of the test substances, as provided to the
test organisms, must be established (e.g., in sensitive insect
bioassays)
(d) Test organisms should be exposed to high concentrations
of the test substance relative to predicted exposures in the
field (if possible) or dose-response studies should be
performed
(e) Exposure of the test organisms to the test substance
should be confirmed by, for example, use of a positive
control and diet analysis to measure the concentration of
the test substance
(f) Endpoints should be measured that are likely to indicate
the possibility of adverse effects on the abundance of
NTAs or other assessment endpoints. Risk assessors
should agree on how to interpret and use these data in the
risk assessment. Determination of the measurement
endpoint(s) should consider the knowledge about the
impact of the arthropod-active protein on the target
organisms, knowledge about the biology of the selected
NTA species and life-stages, and the availability of reliable
test protocols
(g) The number of replicates in the study should be such that
defined effect sizes can be detected with sufficient
statistical power
(h) Negative control treatments must be included to assess
the suitability of the test system, the organisms (e.g.,
health) and the test conditions, and to evaluate potential
effects of the matrix or formulation in which the test
substance is delivered. Test results from assays with
unacceptable high negative control mortality should be
discarded
(i) Positive control treatments should be included, where
feasible, to demonstrate that the test system is able to
detect treatment effects
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Annex 1. Glossary of terms
Arthropod-active protein: The active protein in a GE plant that causes the intended effects on the target organisms
(i.e., the arthropod pests).
Assessment endpoint: An explicit expression of the environmental value that is to be protected. Operationally, it is
defined by an identified environmental entity of value (e.g., beneficial arthropods) that is
susceptible to harm and an attribute that provides evidence of harm (e.g., arthropod
abundance).
Bacillus thuringiensis (Bt): A common soil bacterium, notable for its ability to produce proteins which are toxic to
certain insect groups (see Cry proteins).
Carrier: Matrix used to expose test organisms to a test substance. Carriers can be water, artificial
diets, or arthropods containing the test substance. (see Diet).
Concentration: Quantity of a test substance contained in a diet or other matrix (e.g., plant material), for
example expressed as ng/mg, mg/kg, ng/ml, mg/L, etc.
Cry proteins: A class of crystalline proteins produced by Bacillus thuringiensis bacteria that are toxic to
specific insect taxa.
Diet: In the context of laboratory-based toxicity testing of non-target organisms, material into
which test substance is incorporated to enable oral exposure of test organisms.
Dose: Total amount of a test substance administered to, taken, or absorbed by an organism.
EC50: Effective concentration; concentration of a test substance in a diet or any other matrix that
has a defined effect (for example, growth inhibition) on fifty percent of the population of a
test organism.
ED50: Effective dose; amount of a test substance that has a defined effect on fifty percent of the
population of a test organism.
Environmental risk assessment
(ERA):
The process of identifying significant risks to the environment, estimating the level of risk,
and determining those risks that require measures to reduce the level of risk (USEPA
1998; Wolt et al. 2010).
Estimated Environmental
Concentration (EEC):
Calculated concentrations of a substance in various environmental compartments based on
calculations using maximum-exposure scenarios (IUPAC 2010).
Exposure: The concentration or dose of an active protein (or any other stressor) encountered by an
organism in the environment.
LC50: Lethal concentration; concentration of a test substance in a diet or any other matrix that
causes the death of fifty percent of the population of a test organism.
LD50: Lethal dose; amount of a test substance which causes the death of fifty percent of the
population of a test organism.
Lowest Observed Adverse Effect
Concentration (LOAEC):
The lowest concentration of a test substance found by experiment or observation that causes
an adverse effect on an organism.
Maximum Hazard Dose (MHD): The dose chosen to represent an extreme exposure scenario, calculated using the EEC and
incorporating an additional margin of exposure.
Measurement endpoint: A quantifiable response to the changed characteristic of the plant (i.e., the stressor) that is
related to the assessment endpoint. Examples include: mortality, growth (weight),
development.
Mode of action (MOA): Specific biochemical interaction or mechanism through which a compound produces its
toxic effect.
Negative control: Test organisms put through an experimental protocol that are not exposed to the test
substance, but may be exposed to the carrier (e.g., an artificial diet) in which the test
substance is contained. This is a test of the protocol that helps minimize false positives.
No Observed Adverse Effects
Concentration (NOAEC):
The highest concentration or dose used in a test at which no adverse effects were observed.
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